SAN FRANCISCO -- For patients with recurrent prostate cancer, those with a certain subtype had clinically meaningful benefits ...
Experiencing frequent rage and irritability? It could be Irritable Male Syndrome (IMS), a term gaining acceptance for ...
A new randomized study finds that a lab test that reads tumor genes can identify which patients with recurrent prostate ...
A new clinical trial finds that people with a limited number of metastases from recurrent prostate cancer lived significantly ...
The MARCAP Consortium is the largest independent data repository and statistical analysis team, with Dr. Spratt and Dr. Amar Kishan as co-primary investigators. The purpose of the first MARCAP ...
CAN-2409 improved disease-free survival in patients with intermediate-to-high-risk, localized prostate cancer compared to placebo in patients treated with either conventional or moderate ...
BE honest: if you spot a lump, bump or change down there, are you likely to raise it with a GP or do you just hope it goes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback